Neuravi Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Neuravi Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10408
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neuravi Ltd (Neuravi) is a medical device company that develops and commercializes endovascular devices and stroke treatment. The company provides embotrap revascularization device which is a thrombectomy system designed with clot-device mechanics to address challenging occlusions. Its embotrap revascularization device is a new minimally invasive platform for treating acute ischemic stroke. Neuravi’s initial technology platform addresses acute ischemic stroke. The company is developing clinical data to progress the treatment of stroke. It provides therapies that are based on research into the clot and occlusions causing stroke. It markets its products through its distributors. Neuravi is headquartered in Galway, Ireland.

Neuravi Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neuravi Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Neuravi Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Neuravi Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Neuravi Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Neuravi Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Neuravi Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Neuravi Raises USD16.5 Million in Venture Financing 10
Neuravi Raises USD21.4 Million in Series B Venture Financing 11
Neuravi Raises US$6.4 Million In Series A Financing 13
Acquisition 14
Codman Neuro Acquires Neuravi 14
Neuravi Ltd – Key Competitors 15
Neuravi Ltd – Key Employees 16
Neuravi Ltd – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Neuravi Ltd, Medical Equipment, Key Facts 2
Neuravi Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Neuravi Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Neuravi Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Neuravi Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Neuravi Ltd, Deals By Market, 2012 to YTD 2018 8
Neuravi Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Neuravi Raises USD16.5 Million in Venture Financing 10
Neuravi Raises USD21.4 Million in Series B Venture Financing 11
Neuravi Raises US$6.4 Million In Series A Financing 13
Codman Neuro Acquires Neuravi 14
Neuravi Ltd, Key Competitors 15
Neuravi Ltd, Key Employees 16

List of Figures
Neuravi Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Neuravi Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Neuravi Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Neuravi Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Neuravi Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Neuravi Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Neuravi Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Neuravi Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Neuravi Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Banco Santander SA:戦略・SWOT・企業財務分析
    Banco Santander SA - Strategy, SWOT and Corporate Finance Report Summary Banco Santander SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pharming Group NV (PHARM):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharming Group NV (Pharming) is a specialty pharmaceutical company which develops nutritional products for the treatment of genetic diseases and unmet medical needs. The company’s flagship product, Ruconest (Rhucin in non-European territories) is a recombinant human C1 inhibitor approved for …
  • Titan Company Ltd (TITAN):企業の財務・戦略的SWOT分析
    Summary Titan Company Ltd (Titan) is a retailing company. Its product portfolio includes eyewear, watches and accessories; jewelry; and fashion accessories. The company offers jewelry products comprising of pendant, chain, gold coin, earrings, finger ring and neckwear. Titan offers eyewear products …
  • Eisai Co., Ltd.:企業の戦略・SWOT・財務分析
    Eisai Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Eisai Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Arcadia Biosciences Inc (RKDA):企業の財務・戦略的SWOT分析
    Summary Arcadia Biosciences Inc (Arcadia) is an agricultural and clean technology company that develops and commercializes agricultural products. Its major products include goodwheat branded ingredients, nutritional oils, animal nutrition and agricultural products. The company's products exhibit tra …
  • Johns Hopkins University:医療機器:M&Aディール及び事業提携情報
    Summary Johns Hopkins University (JHU) is a research university which offers undergraduate, graduate, master’s, and doctoral programs. It offers educational services in the areas of arts and sciences, engineering, business, medicine, nursing, public health, and advanced international studies. It als …
  • TAS S.p.A. (TAS):企業の財務・戦略的SWOT分析
    TAS S.p.A. (TAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Balaji Amines Ltd (BALAMINES):企業の財務・戦略的SWOT分析
    Balaji Amines Ltd (BALAMINES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Vista Pharmaceuticals Ltd (524711):企業の財務・戦略的SWOT分析
    Summary Vista Pharmaceuticals Ltd (Vista), a subsidiary of Torrent Pharmaceuticals Ltd, is a pharmaceutical company that offers over the counter and prescription generic products. The company offers drugs in the form of tablets, capsules and liquids for various therapeutic areas. It offers products …
  • Brown-Forman Corporation:戦略・SWOT・企業財務分析
    Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report Summary Brown-Forman Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Petrol dd Ljubljana (PETG):企業の財務・戦略的SWOT分析
    Petrol dd Ljubljana (PETG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Deoleo SA:企業の戦略・SWOT・財務分析
    Deoleo SA - Strategy, SWOT and Corporate Finance Report Summary Deoleo SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Westar Energy Inc (WR):企業の財務・戦略的SWOT分析
    Westar Energy Inc (WR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Louisiana-Pacific Corp (LPX):企業の財務・戦略的SWOT分析
    Louisiana-Pacific Corp (LPX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Synaxon AG:企業の戦略的SWOT分析
    Synaxon AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Japan Oil, Gas and Metals National Corp:企業の戦略的SWOT分析
    Japan Oil, Gas and Metals National Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Longfor Group Holdings Limited:企業の戦略・SWOT・財務情報
    Longfor Group Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Longfor Group Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sinovac Biotech Ltd (SVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Sinovac Biotech Ltd (Sinovac Biotech) is a biopharmaceutical company that develops, manufactures and commercializes vaccines. The company’s products comprise healive, bilive, anflu, panflu and panflu, among others. Its healive is an inactivated hepatitis A vaccine. Sinovac Biotech’s bilive i …
  • Berry Global Group Inc:戦略・SWOT・企業財務分析
    Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report Summary Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • SRI International:医療機器:M&Aディール及び事業提携情報
    Summary SRI International (SRI) is a non-profit organization that provides commercial research and development programs. The organization’s services include research and development, innovation consulting, technology solutions, bioscience contract research, specialized facilities and services. It pe …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆